Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 27, 2020

View Archived Issues

Structural insights could enable specific activation of GPCRs

Autophagy activation may prevent metastasis

S100A12 is upregulated in papillary thyroid cancer and may serve as a diagnostic biomarker

New MRI contrast agent specifically targeting CXCR4 in liver metastases may allow early detection

Pilot study of APN-01 for the treatment of coronavirus disease COVID-19 in China

Novavax produces nanoparticle COVID-19 vaccine candidates

Prospective comparison of [68Ga]RM-2 and [68Ga]PSMA-617 PET/CT in prostate cancer

Proof-of-concept data for novel anti-CD300f ADC in preclinical models of AML

Generon presents phase II data for F-652 in acute GVHD

Positive initial data from phase IIa study of IFX-1 in Pyoderma gangraenosum

Conserved epigenetic regulators prevent healthy aging

Tonix collaborates with Southern Research on vaccine TNX-1800 for COVID-19

Sitagliptin for preventing aGvHD following myeloablative allogeneic transplantation shows promise

FDA clears start of investigator-sponsored trial of Kiadis' off-the-shelf NK cell therapy for AML

IL-6 blockade investigated in stem cell transplantation for multiple myeloma

ViiV Healthcare presents new antivirals for HIV infection

Gilead Sciences patents IRAK-4 inhibitors

Medshine Discovery discloses RET inhibitors

G1 Therapeutics identifies ER modulators

Inflazome completes first-in-human study of NLRP3 inflammasome inhibitor somalix

Genentech and Roche divulge KRAS inhibitors

MapKure initiates first-in-human study of BGB-3245 in advanced or refractory tumors

FDA approves Barhemsys for prevention and treatment of PONV

iTeos initiates phase I/II study of EOS-884448 in advanced cancers

Ascletis updates clinical trial in China with Ganovo and ritonavir for novel coronavirus pneumonia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...